BioSpace News Archive

Policy

FDA Action Alert: Epizyme and Merck

January isn’t a particularly busy month for PDUFA dates for the U.S. Food and Drug Administration, with only two scheduled for the month. Here’s a look.

January 17, 2020
·
3 min read
·
Mark Terry
FDA

Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes Patients

For patients with diabetes, the new indication could become a key for survival as there is a well-established link between cardiovascular disease and type 2 diabetes.

January 17, 2020
·
2 min read
·
Alex Keown
Business

Eli Lilly Plans Spending Spree for 2020

Eli Lilly’s senior vice president and chief financial officer Josh Smiley announced plans for the company to spend from $1 billion to $5 billion each quarter this year as it plans to bolster its pipeline.

January 17, 2020
·
3 min read
·
Mark Terry
Policy

Judge to Sentence Former Congressman in Insider Trading Case

Collins, a former member of the Innate Immunotherapeutics Board of Directors, was indicted in 2018 and resigned his seat last year.

January 17, 2020
·
2 min read
·
Alex Keown
Job Trends

Clinical Catch-Up: January 13-17

There were plenty of clinical trial announcements this week. Here’s a look.

January 17, 2020
·
7 min read
·
Mark Terry
Policy

FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug

Posimir is a non-opioid being developed for post-surgical pain. It is designed to be injected into the surgical site, where it delivers bupivacaine for up to three days post-surgery.

January 17, 2020
·
2 min read
·
Mark Terry
Deals

BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline

“This acquisition fits with our strategy to expand our capabilities and build our presence in the U.S. and further strengthens our immunotherapy pipeline,” said Ugur Sahin, co-founder and chief executive officer of BioNTech.

January 17, 2020
·
2 min read
·
Mark Terry
Deals

Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry

Deal expands Life Sciences services and solutions portfolio to enable customers worldwide to accelerate life-changing innovations and improve patient outcomes and access

January 17, 2020
·
19 min read
Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness

Technology being developed aims to bridge the gap between the high cost of treatment for corneal blindness and the unmet medical need in poor communities worldwide.

January 17, 2020
·
5 min read
Business

Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2019 before the US financial markets open on January 30, 2020

January 17, 2020
·
1 min read